Cigna Corp. (CI) Tops Q3 EPS by 28c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CIGNA (CI) PT Raised to $394 at Piper Sandler
November 4, 2024 4:04 PM ESTPiper Sandler analyst Jessica Tassan raised the price target on CIGNA (NYSE: CI) to $394.00 (from $392.00) while maintaining a Overweight rating.
The analyst comments "CI reported a pharmacy-led 3Q24 adjusted EPS beat and reiterated adjusted CY24 guidance. Notwithstanding the asset sale at Cigna Healthcare and... More
CIGNA (CI) PT Lowered to $406 at Jefferies
November 1, 2024 5:45 AM EDTJefferies analyst David Windley lowered the price target on CIGNA (NYSE: CI) to $406.00 (from $422.00) while maintaining a Buy rating.
The analyst comments "To our ears, the response to HUM headlines has been consistent (on our Sept NDR and the call): not... More
